BICO Group AB (publ) (STO:BICO)

Inozyme Pharma Revenue

BICO Group AB had revenue of 388.60M SEK in the quarter ending March 31, 2025, a decrease of -17.35%. This brings the company's revenue in the last twelve months to 1.86B, down -6.39% year-over-year. In the year 2024, BICO Group AB had annual revenue of 1.95B, down -3.19%.

• Revenue (ttm): 1.86B
• Revenue Growth: -6.39%
• P/S Ratio: 1.36
• Revenue / Employee: 2.68M
• Employees: 710
• Market Cap: 2.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.95B	-64.10M	-3.19%
Dec 31, 2023	2.01B	-316.50M	-13.60%
Dec 31, 2022	2.33B	948.80M	68.85%
Dec 31, 2021	1.38B	1.01B	273.47%
Dec 31, 2020	369.00M	133.25M	56.52%